Yann Seimbille

3.0k total citations · 1 hit paper
77 papers, 2.2k citations indexed

About

Yann Seimbille is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Yann Seimbille has authored 77 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Radiology, Nuclear Medicine and Imaging, 24 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Yann Seimbille's work include Radiopharmaceutical Chemistry and Applications (28 papers), Medical Imaging Techniques and Applications (17 papers) and Peptidase Inhibition and Analysis (11 papers). Yann Seimbille is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Medical Imaging Techniques and Applications (17 papers) and Peptidase Inhibition and Analysis (11 papers). Yann Seimbille collaborates with scholars based in Netherlands, Canada and Switzerland. Yann Seimbille's co-authors include Didier Colin, Siegfried Hapfelmeier, Mirko Trajkovski, Ana Stevanović, Christelle Veyrat‐Durebex, Xavier Montet, Ozren Stojanović, Claire Chevalier, Salvatore Fabbiano and Dorothée Rigo and has published in prestigious journals such as Cell, Nature Medicine and ACS Nano.

In The Last Decade

Yann Seimbille

73 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbiota Orchestrates Energy Homeostasis during Cold

2015 596 citations Claire Chevalier, Ozren Stojanović et al. Cell profile →

Peers

Countries citing papers authored by Yann Seimbille

Since Specialization

Citations

This map shows the geographic impact of Yann Seimbille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yann Seimbille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yann Seimbille more than expected).

Fields of papers citing papers by Yann Seimbille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yann Seimbille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yann Seimbille. The network helps show where Yann Seimbille may publish in the future.

Co-authorship network of co-authors of Yann Seimbille

This figure shows the co-authorship network connecting the top 25 collaborators of Yann Seimbille. A scholar is included among the top collaborators of Yann Seimbille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yann Seimbille. Yann Seimbille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lead radionuclides for theranostic applications in nuclear medicine: from atom to bedside 2025 ·Theranostics ·(unknown), (unknown), (unknown), Karolien Goffin, Kristof Baete, Michel Koole, An Coosemans, T. E. Cocolios, Christophe M. Deroose, Yann Seimbille, Frederik Cleeren	0
2	Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer 2025 ·Bioconjugate Chemistry ·Hanyue Ma, (unknown), (unknown), (unknown), (unknown), (unknown), Lukas J.A.C. Hawinkels, J. Sven D. Mieog, Alexander L. Vahrmeijer, Yann Seimbille	0
3	Ac-225 radiochemistry through the lens of [225Ac]Ac-DOTA-TATE 2025 ·EJNMMI Radiopharmacy and Chemistry ·(unknown), (unknown), (unknown), Frank Bruchertseifer, Aliyah Morgenstern, Yann Seimbille, Tessa Brabander, Stijn L.W. Koolen, Erik de Blois	4
4	eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors 2024 ·EJNMMI Radiopharmacy and Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Debra Stuurman, Yann Seimbille	1
5	Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics 2023 ·Pharmaceuticals ·(unknown), (unknown), (unknown), (unknown), Debra Stuurman, (unknown), Frederik Cleeren, Yann Seimbille	2
6	[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors 2023 ·Pharmaceuticals ·(unknown), (unknown), (unknown), (unknown), (unknown), Debra Stuurman, Erik de Blois, (unknown), Karlijn van der Schilden, Marion de Jong, Mark Konijnenberg, Yann Seimbille	11
7	Synthesis, Fluorine-18 Radiolabeling, and In Vivo PET Imaging of a Hydrophilic Fluorosulfotetrazine 2023 ·Pharmaceuticals ·(unknown), Stéphane Guillouet, Yann Seimbille, Cécile Perrio	6
8	Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer 2023 ·Molecules ·(unknown), (unknown), (unknown), (unknown), Debra Stuurman, (unknown), Yann Seimbille	5
9	Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), (unknown), Debra Stuurman, Yann Seimbille, Simone U. Dalm	11
10	Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy 2021 ·Cancers ·(unknown), Mark W. H. Hoorens, Simone U. Dalm, (unknown), Reno Debets, Yann Seimbille, Marion de Jong	46
11	In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors 2021 ·Contrast Media & Molecular Imaging ·(unknown), Erik de Blois, Joost Haeck, Yann Seimbille, Laura Mezzanotte, Marion de Jong, Clemens W.G.M. Löwik, Kranthi M. Panth	5
12	Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC 2021 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Marcel Segbers, Frank Bruchertseifer, Aliyah Morgenstern, Yann Seimbille, Stijn L.W. Koolen, Tessa Brabander, Erik de Blois	36
13	Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Valentina Garibotto, Michael Wissmeyer, (unknown), Rachel Goldstein, Yann Seimbille, Margitta Seeck, Osman Ratib, Sven Haller, Fabienne Picard	11
14	Early‐Stage Incorporation Strategy for Regioselective Labeling of Peptides using the 2‐Cyanobenzothiazole/ 1,2‐Aminothiol Bioorthogonal Click Reaction 2018 ·ChemistryOpen ·Kuo‐Ting Chen, Christian Ieritano, Yann Seimbille	3
15	Gut Microbiota Orchestrates Energy Homeostasis during Cold breakdown → 2015 ·Cell ·Claire Chevalier, Ozren Stojanović, Didier Colin, Nicolas Suárez-Zamorano, (unknown), Christelle Veyrat‐Durebex, Dorothée Rigo, Salvatore Fabbiano, Ana Stevanović, Stefanie Hagemann, Xavier Montet, Yann Seimbille, Nicola Zamboni, Siegfried Hapfelmeier, Mirko Trajkovski	596
16	Microbiota depletion promotes browning of white adipose tissue and reduces obesity 2015 ·Nature Medicine ·Nicolas Suárez-Zamorano, Salvatore Fabbiano, Claire Chevalier, Ozren Stojanović, Didier Colin, Ana Stevanović, Christelle Veyrat‐Durebex, (unknown), Dorothée Rigo, Stéphane Germain, (unknown), Xavier Montet, Yann Seimbille, Siegfried Hapfelmeier, Mirko Trajkovski	310
17	Synthesis and in vitro evaluation of a novel radioligand for αvβ3 integrin receptor imaging: [18F]FPPA-c(RGDfK) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Alessandra Monaco, Vincent Zoete, Gian Carlo Alghisi, Curzio Rüegg, (unknown), John O. Prior, Léonardo Scapozza, Yann Seimbille	8
18	Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight 2012 ·Journal of Nuclear Cardiology ·Gabriella Vincenti, Giuseppe Ambrosio, Jean‐Noël Hyacinthe, Alessandra Quercioli, Yann Seimbille, François Mach, Osman Ratib, Jean‐Paul Vallée, Thomas H. Schindler	2
19	Kombinierte Untersuchung der myokardialen Perfusion und koronaren Morphologie für die Identifizierung einer subklinischen koronarer Herzerkrankung (KHK) 2010 ·Nuklearmedizin - NuclearMedicine ·Gabriella Vincenti, Alessandra Quercioli, Habib Zaidi, René Nkoulou, (unknown), Olivier Rager, Giuseppe Ambrosio, Yann Seimbille, François Mach, Osman Ratib, Thomas H. Schindler	2
20	Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD 2010 ·Nuklearmedizin - NuclearMedicine ·Gabriella Vincenti, Alessandra Quercioli, Habib Zaidi, René Nkoulou, (unknown), Olivier Rager, Giuseppe Ambrosio, Yann Seimbille, François Mach, Osman Ratib, Thomas H. Schindler	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact